European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.6% to 1,436.74 on the S&P Europe Select ADR Index. From continental Europe, the
Market Chatter: Grifols Stakeholder Scranton Enterprises Said in Talks for EUR130 Million Loan
A shareholder of Spanish specialty pharmaceutical company Grifols (GRF.MC) is reportedly negotiating a potential 130 million-euro loan deal with Oaktree Capital Management. Spanish online newspaper El
Grifols Shareholder Scranton Inks Debt Deal for Plasma Unit
Grifols Shareholder Scranton Reported to Seek Loan From Oaktree
Scranton Enterprises, a major shareholder of Spanish pharmaceutical company Grifols SA, is in talks with Oaktree Capital Management for a €130 million ($140 million) credit line, according to a report by El Confidencial.
Grifols' Biotest Set to Launch Intravenous Immunoglobulin in US in Q1 2025
Grifols' (GRF.MC) Biotest will launch its intravenous immunoglobulin Yimmugo in the US in the first quarter of 2025 after receiving US Food and Drug Administration approval for the treatment of primar
Grifols's Subsidiary Biotest Forecasts Approximately $1B In Revenue From Sales In The U.S. Of Its Intravenous Immunoglobulin Yimmugo During The Next Seven Years, Following Recent FDA Approval To Treat Primary Immunodeficiencies
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter 2025Yimmugo will be distributed by Kedrion in the U.S. as part
Grifols Says At End June 2024, Considering SRAAS Proceeds, Leverage Ratio Is Expected To Reach 5.4x Vs. 6.8x In March 2024; FCF In Q2 2024 Expected To Be Positive, Contributing To Reach €5 Million FY24 Guidance, Which Includes €480 Million Of...
Grifols Says At End June 2024, Considering SRAAS Proceeds, Leverage Ratio Is Expected To Reach 5.4x Vs. 6.8x In March 2024; FCF In Q2 2024 Expected To Be Positive, Contributing To Reach €5 Million FY2
Grifols Says €1.6 Billion Net Cash Proceeds From Sale Of 20% Equity Stake In Shanghai RAAS Are Currently Deposited In Co's Bank Account; Proceeds Will Be Fully Allocated To Reduce 2025 Senior Secured Notes And 2027 Term Loan B And On A Pro-Rata Basis...
Grifols Says €1.6 Billion Net Cash Proceeds From Sale Of 20% Equity Stake In Shanghai RAAS Are Currently Deposited In Co's Bank Account; Proceeds Will Be Fully Allocated To Reduce 2025 Senior Secured
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.27% to 1,423.98 on the S&P Europe Select ADR Index. From continental Europe, the gainers
Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Thursday.Shares of Levi Strauss & Co. (NYSE:LEVI) fell sharply in today's pre-market trading after the compan
Grifols Shares Fall After Credit Downgrade by Moody's Ratings
By Pierre Bertrand Grifols shares fell Thursday after Moody's Ratings downgraded the Spanish pharmaceutical company's credit rating, citing in part its high indebtedness, opaque organizational struct
Moody's Downgrades Grifols on Delayed Free Cash Flow Recovery, High Leverage
Moody's said Wednesday it lowered Grifols' (GRF.MC) corporate family rating to B3 from B2, with a stable outlook, finalizing the review for downgrade launched in March. The rating agency said the down
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Tuesday morning, rising 0.18% to 1,428.31 on the S&P Europe Select ADR Index. From continental Eur
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts were trending higher Monday, rising 0.84% to 1,428.35 on the S&P Europe Select ADR Index. From continental Europe, the gainers were l
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending moderately higher late Thursday morning, rising 0.62% to 1,426.64 on the S&P Europe Select ADR Index. From continental
Grifols Raised to Hold From Sell by Deutsche Bank
Grifols Raised to Hold From Sell by Deutsche Bank
RAAS Blood Products Renews Cooperation Deal With Spain's Grifols
Shanghai RAAS Blood Products (SHE:002252) renewed its cooperation agreement with Spanish healthcare company Grifols, according to a Tuesday filing on the Shenzhen Stock Exchange. Both parties will con
Deutsche Numis Upgrades Grifols(GRFS.US) to Hold Rating
Deutsche Numis analyst Emmanuel Papadakis upgrades $Grifols(GRFS.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 58.9% and a total average return of 5.9% over the p
Grifols completed the sale of 20% of Shanghai RAAS Blood Products shares and reached a global strategy cooperation agreement with Haier Group.
With the announcement of today's completed transaction, Grifols and Haier will cooperate through Shanghai RAAS to enhance China's medical care system with synergies. Under the share purchase agreement, Grifols will sell 20% of Shanghai RAAS's shares to Haier Group for RMB 12.5 billion (approximately €1.6 billion). Grifols and Shanghai RAAS will extend their exclusive agency agreement for albumin for the next 10 years, and Shanghai RAAS may choose to extend it to 2044. All of Grifols' revenue will be used to fulfill its deleveraging commitments. Shanghai, June 18, 2024 /PRNewswire/-- Global medical and health companies and leaders.